Journals / Klinik Psikofarmakoloji Bülteni / 2014 / Cilt: 24 - Sayı: 1

Elektrokonvülsif terapide anestezik ajanların ve tanıların nöbet süreleri, derlenme süreleri ve komplikasyonlar üzerine olan etkilerinin değerlendirilmesi

Evaluation of the effects of anesthetic agents and diagnoses on seizure durations, recovery times and complications in electroconvulsive therapy

Pages
23–30
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The seizure and recovery times were significantly shorter in the propofol group compared to the ketamine and etomidate groups (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The aim of this study is to retrospectively evaluate the influence of diagnosis and three different anesthetic agents on seizure durations, hemodynamic parameters, recovery times, and side effects in electroconvulsive therapy (ECT).
📊
Key Findings & Data:Method: We have retrospectively evaluated 1342 ECT sessions conducted on 179 patients under general anesthesia at the Psychiatry Department of Dicle University Hospital between 1 September 2009 and 30 June 2012.
💡
Conclusion & Impact:The seizure and recovery times were significantly shorter in the propofol group compared to the ketamine and etomidate groups (p
🔬Design:Research Article
📍Scope:2009 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: The aim of this study is to retrospectively evaluate the influence of diagnosis and three different anesthetic agents on seizure durations, hemodynamic parameters, recovery times, and side effects in electroconvulsive therapy (ECT). Method: We have retrospectively evaluated 1342 ECT sessions conducted on 179 patients under general anesthesia at the Psychiatry Department of Dicle University Hospital between 1 September 2009 and 30 June 2012. The relationship between the indications for ECT and the choice of anesthetic agent, number of ECT sessions, motor and EEG seizure durations, recovery times from anesthesia, hemodynamic changes and complications were analysed. Results: The mean age of the 179 patients included in the study was 36.7±7.3 years. In terms of sex, 50.8% (n=91) were male and 49.2% (n=88) were female. The most commonly used anesthetic agent was propofol (73.2%). Among the patients, 50.8% was diagnosed with major depression, 28.5% had bipolar disorder and 12.8% was diagnosed with schizophrenia. A total of 179 (13.3%) out of the 1342 ECT sessions were considered as failed. In 92.2% of the failed ECTs, the anesthetic agent was propofol. No statistically significant relationship was observed between the diagnosis forming the basis for the ECT and the motor and EEG seizure times, beginning of spontaneous breathing, eye opening, time until response to verbal stimuli, changes in hemodynamic parameters and complications. The seizure and recovery times were significantly shorter in the propofol group compared to the ketamine and etomidate groups (p

Özet

Amaç: Bu çalışmada elektrokonvulzif terapi (EKT)anestezisinde kullanılan üç farklı anestezik ajanın vetanıların nöbet süreleri, hemodinamik parametreler,derlenme süreleri ve yan etkiler üzerine olan etkilerinin retrospektif olarak değerlendirilmesi amaçlandı. Yöntem: 1 Eylül 2009-30 Haziran 2012 tarihleri arasındaDicle Üniversitesi Psikiyatri Kliniğinde EKT endikasyonu konulan ve genel anestezi altında EKT uygulanan toplam179 hastanın 1342 EKT seansı retrospektif olarak incelendi. EKT endikasyonları ve kullanılan anestezik ajanların,uygulanan EKT sayısı, motor ve EEG nöbet süreleri,anesteziden derlenme süreleri, hemodinamik değişikliklerve komplikasyonlar ile ilişkisi analiz edildi.Bulgular: Çalışmaya dahil edilen 179 hastanın yaş ortalaması 36.7±7.3 yıl idi. %50.8’i (n=91) erkek, %49.2’si(n=88) kadındı. En çok kullanılan anestezik ajan propofol idi(%73.2). Hastaların %50.8 major depresyon, %28.5’i bipolarbozukluk, %12.8’i şizofreni tanısıyla takip edilmekteydi.Uygulanan toplam 1342 EKT seansının 179’u (%13.3)başarısız olarak kabul edildi. Başarısız EKT’lerin %92.2’sinde propofol anestezisi kullanılmıştı. Elektrokonvulzif terapi endikasyonu koyduran tanıların motor ve EEG nöbet süreleri, spontan solunum başlangıcı, göz açma, sözel uyaranlarayanıt verme süreleri, hemodinamik parametrelerdeki değişiklikler ve komplikasyonlar arasında istatistiksel olarak anlamlı ilişki saptanmadı. Propofol grubunda nöbet ve derlenme süreleri ketamin ve etomidat gruplarına göreanlamlı olarak daha kısaydı (p

🔖

Cite This Article

BULUT, M., ATLI, A., TUFEK, A., TOKGOZ, O., CELİK, F., BAYSAL, Z. Y., KARAMAN, H., KAYA, M. C. (2022). Elektrokonvülsif terapide anestezik ajanların ve tanıların nöbet süreleri, derlenme süreleri ve komplikasyonlar üzerine olan etkilerinin değerlendirilmesi. Klinik Psikofarmakoloji Bülteni, Cilt: 24 - Sayı: 1, 23–30. https://ajindex.com/articles/574007

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Geretsegger C, Nickel M, Judendorfer B, Rochowanski E, Novak E, Aichhorn W. Propofol and methohexital as anesthetic agents for electroconvulsive therapy: a randomised, double-blind comparison of electroconvulsive therapy seizure quality, therapeutic efficacy, and cognitive performance. J ECT 2007
  2. 23(4):239-43. [CrossRef] 2. Ding Z, White PF. Anesthesia for electroconvulsive therapy. Anesth Analg 2002
  3. 94(5):1351-64. [CrossRef] 3. Smith DL, Angst MS, Brock-Utne JG, DeBattista C. Seizure duration with remifentanil/methohexital vs. methohexital alone in middle-aged patients undergoing electroconvulsive therapy. Acta Anaesthesiol Scand 2003
  4. 47(9):1064-6. [CrossRef] 4. Simpson KH, Lynch L. Anaesthesia and electroconvulsive therapy (ECT). Anaesthesia 1998
  5. 53(7):615-7. [CrossRef] 5. Basgul E, Celiker V. Anaesthesia in electroconvulsive therapy. Turk Psikiyatri Derg 2004
  6. 15(3):225-35. 6. Folk JW, Kellner CH, Beale MD, Conroy JM, Duc TA. Anesthesia for electroconvulsive therapy: a review. J ECT 2000
  7. 16(2):157-70. [CrossRef] 7. Hooten WM, Rasmussen KG, Jr. Effects of general anesthetic agents in adults receiving electroconvulsive therapy: a systematic review. J ECT 2008
  8. 24(3):208-23. [CrossRef] 8. Bailine SH, Petrides G, Doft M, Lui G. Indications for the use of propofol in electroconvulsive therapy. J ECT 2003
  9. 19(3):129-32. [CrossRef] 9. Berman RM, Cappiello A, Anand A, Oren DA, Heninger GR, Charney DS, et al. Antidepressant effects of ketamine in depressed patients. Biol Psychiatry 2000
  10. 47(4):351-4. [CrossRef] 10. Zarate CA, Jr., Singh JB, Carlson PJ, Brutsche NE, Ameli R, Luckenbaugh DA, et al. A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry 2006
  11. 63(8):856-64. [CrossRef] 11. Chung KF. Determinants of seizure threshold of electroconvulsive therapy in Chinese. J ECT 2006
  12. 22(2):100- 2. [CrossRef] 12. Colenda CC, McCall WV. A statistical model predicting the seizure threshold for right unilateral ECT in 106 patients. Convuls Ther 1996
  13. 12(1):3-12. 13. McCall WV, Shelp FE, Weiner RD, Austin S, Norris J. Convulsive threshold differences in right unilateral and bilateral ECT. Biol Psychiatry 1993
  14. 34(9):606-11. [CrossRef] 14. Sackeim HA, Devanand DP, Prudic J. Stimulus intensity, seizure threshold, and seizure duration: impact on the efficacy and safety of electroconvulsive therapy. The Psychiatric clinics of North America 1991
  15. 14(4):803-43. 15. Fredman B, d’Etienne J, Smith I, Husain MM, White PF. An